Binocrit

国家: 欧盟

语言: 英文

来源: EMA (European Medicines Agency)

现在购买

资料单张 资料单张 (PIL)
21-11-2023
产品特点 产品特点 (SPC)
21-11-2023
公众评估报告 公众评估报告 (PAR)
04-10-2018

有效成分:

epoetin alfa

可用日期:

Sandoz GmbH

ATC代码:

B03XA01

INN(国际名称):

epoetin alfa

治疗组:

Antianemic preparations

治疗领域:

Anemia; Kidney Failure, Chronic

疗效迹象:

Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis;, Treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy).

產品總結:

Revision: 22

授权状态:

Authorised

授权日期:

2007-08-28

资料单张

                                75
B. PACKAGE LEAFLET
76
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
BINOCRIT 1,000 IU/0.5 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 2,000 IU/1 ML SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE
BINOCRIT 3,000 IU/0.3 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 4,000 IU/0.4 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 5,000 IU/0.5 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 6,000 IU/0.6 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 7,000 IU/0.7 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 8,000 IU/0.8 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 9,000 IU/0.9 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 10,000 IU/1 ML SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE BINOCRIT 20,000 IU/0.5 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE BINOCRIT 30,000 IU/0.75 ML SOLUTION FOR INJECTION IN A PRE-FILLED
SYRINGE
BINOCRIT 40,000 IU/1 ML SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE
Epoetin alfa
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Binocrit is and what it is used for
2.
What you need to know before you use Binocrit
3.
How to use Binocrit
4.
Possible side effects
5.
How to store Binocrit
6.
Contents of the pack and other information
1.
WHAT BINOCRIT IS AND WHAT IT IS USED FOR
Binocrit contains the active substance epoetin alfa, a protein that
stimulates the bone marrow to
produce more red blood cells which carry haemoglobin (a substance that
transports oxygen). Epoe
                                
                                阅读完整的文件
                                
                            

产品特点

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled
syringe
Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe
Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled
syringe
Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled
syringe
Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled
syringe
Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled
syringe
Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled
syringe
Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled
syringe
Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled
syringe
Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe
Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled
syringe
Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled
syringe
Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled
syringe
Each mL of solution contains 2,000 IU of epoetin alfa
*
corresponding to 16.8 micrograms per mL
A pre-filled syringe of 0.5 mL contains 1,000 international units (IU)
corresponding to 8.4 micrograms
epoetin alfa. *
Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe
Each mL of solution contains 2,000 IU of epoetin alfa
*
corresponding to 16.8 micrograms per mL
A pre-filled syringe of 1 mL contains 2,000 international units (IU)
corresponding to 16.8 micrograms
epoetin alfa. *
Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled
syringe
Each mL of solution contains 10,000 IU of epoetin alfa
*
corresponding to 84.0 micrograms per mL
A pre-filled syringe of 0.3 mL contains 3,000 international units (IU)
corresponding
to 25.2 micrograms epoetin alfa. *
Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled
syringe
Each mL of solution contains 10,000 IU of epoetin alfa
*

                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 保加利亚文 21-11-2023
产品特点 产品特点 保加利亚文 21-11-2023
公众评估报告 公众评估报告 保加利亚文 04-10-2018
资料单张 资料单张 西班牙文 21-11-2023
产品特点 产品特点 西班牙文 21-11-2023
公众评估报告 公众评估报告 西班牙文 04-10-2018
资料单张 资料单张 捷克文 21-11-2023
产品特点 产品特点 捷克文 21-11-2023
公众评估报告 公众评估报告 捷克文 04-10-2018
资料单张 资料单张 丹麦文 21-11-2023
产品特点 产品特点 丹麦文 21-11-2023
公众评估报告 公众评估报告 丹麦文 04-10-2018
资料单张 资料单张 德文 21-11-2023
产品特点 产品特点 德文 21-11-2023
公众评估报告 公众评估报告 德文 04-10-2018
资料单张 资料单张 爱沙尼亚文 21-11-2023
产品特点 产品特点 爱沙尼亚文 21-11-2023
公众评估报告 公众评估报告 爱沙尼亚文 04-10-2018
资料单张 资料单张 希腊文 21-11-2023
产品特点 产品特点 希腊文 21-11-2023
公众评估报告 公众评估报告 希腊文 04-10-2018
资料单张 资料单张 法文 21-11-2023
产品特点 产品特点 法文 21-11-2023
公众评估报告 公众评估报告 法文 04-10-2018
资料单张 资料单张 意大利文 21-11-2023
产品特点 产品特点 意大利文 21-11-2023
公众评估报告 公众评估报告 意大利文 04-10-2018
资料单张 资料单张 拉脱维亚文 21-11-2023
产品特点 产品特点 拉脱维亚文 21-11-2023
公众评估报告 公众评估报告 拉脱维亚文 04-10-2018
资料单张 资料单张 立陶宛文 21-11-2023
产品特点 产品特点 立陶宛文 21-11-2023
公众评估报告 公众评估报告 立陶宛文 04-10-2018
资料单张 资料单张 匈牙利文 21-11-2023
产品特点 产品特点 匈牙利文 21-11-2023
公众评估报告 公众评估报告 匈牙利文 04-10-2018
资料单张 资料单张 马耳他文 21-11-2023
产品特点 产品特点 马耳他文 21-11-2023
公众评估报告 公众评估报告 马耳他文 04-10-2018
资料单张 资料单张 荷兰文 21-11-2023
产品特点 产品特点 荷兰文 21-11-2023
公众评估报告 公众评估报告 荷兰文 04-10-2018
资料单张 资料单张 波兰文 21-11-2023
产品特点 产品特点 波兰文 21-11-2023
公众评估报告 公众评估报告 波兰文 04-10-2018
资料单张 资料单张 葡萄牙文 21-11-2023
产品特点 产品特点 葡萄牙文 21-11-2023
公众评估报告 公众评估报告 葡萄牙文 04-10-2018
资料单张 资料单张 罗马尼亚文 21-11-2023
产品特点 产品特点 罗马尼亚文 21-11-2023
公众评估报告 公众评估报告 罗马尼亚文 04-10-2018
资料单张 资料单张 斯洛伐克文 21-11-2023
产品特点 产品特点 斯洛伐克文 21-11-2023
公众评估报告 公众评估报告 斯洛伐克文 04-10-2018
资料单张 资料单张 斯洛文尼亚文 21-11-2023
产品特点 产品特点 斯洛文尼亚文 21-11-2023
公众评估报告 公众评估报告 斯洛文尼亚文 04-10-2018
资料单张 资料单张 芬兰文 21-11-2023
产品特点 产品特点 芬兰文 21-11-2023
公众评估报告 公众评估报告 芬兰文 04-10-2018
资料单张 资料单张 瑞典文 21-11-2023
产品特点 产品特点 瑞典文 21-11-2023
公众评估报告 公众评估报告 瑞典文 04-10-2018
资料单张 资料单张 挪威文 21-11-2023
产品特点 产品特点 挪威文 21-11-2023
资料单张 资料单张 冰岛文 21-11-2023
产品特点 产品特点 冰岛文 21-11-2023
资料单张 资料单张 克罗地亚文 21-11-2023
产品特点 产品特点 克罗地亚文 21-11-2023
公众评估报告 公众评估报告 克罗地亚文 04-10-2018

搜索与此产品相关的警报

查看文件历史